ARCOMA — Arcoma AB Income Statement
0.000.00%
Last trade - 00:00- SEK153.61m
- SEK152.48m
- SEK163.02m
- 91
- 38
- 72
- 78
Annual income statement for Arcoma AB, fiscal year end - December 31st, SEK millions except per share, conversion factor applied.
2019 December 31st | 2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | ARS | ARS | ARS | ARS | ARS |
| Standards: | IFRS | — | — | — | IFRS |
| Status: | Final | Final | Final | Final | Final |
| Revenue | |||||
| Total Revenue | 134 | 117 | 117 | 125 | 163 |
| Cost of Revenue | |||||
| Gross Profit | 51.9 | 45.3 | 41.6 | 50.4 | 57.9 |
| Selling / General / Administrative Expenses | |||||
| Depreciation and Amortization | |||||
| Unusual Expense / Income | |||||
| Other Operating Expenses | |||||
| Total Operating Expenses | 125 | 114 | 126 | 122 | 158 |
| Operating Profit | 9.1 | 3.51 | -8.79 | 3.13 | 4.66 |
| Total Net Non Operating Interest Income / Expense | |||||
| Other Net Non Operating Costs | |||||
| Net Income Before Taxes | 8.89 | 1.75 | -8.91 | 2.12 | 3.13 |
| Provision for Income Taxes | |||||
| Net Income After Taxes | 6.61 | 1.36 | -7.47 | 1.9 | 2.56 |
| Net Income Before Extraordinary Items | |||||
| Net Income | 6.61 | 1.36 | -7.47 | 1.9 | 2.56 |
| Adjustments to Net Income | |||||
| Income Available to Common Shareholders Excluding Extraordinary Items | |||||
| Income Available to Common Shareholders Including Extraordinary Items | |||||
| Diluted Net Income | 6.61 | 1.36 | -7.47 | 1.9 | 2.56 |
| Diluted Weighted Average Shares | |||||
| Basic EPS Including Extraordinary Items | |||||
| Diluted EPS Including Extraordinary Items | |||||
| Diluted EPS Excluding Extraordinary Items | |||||
| Normalised Income Before Taxes | |||||
| Normalised Income After Taxes | |||||
| Normalised Income Available to Common Shareholders | |||||
| Diluted Normalised EPS | 0.602 | 0.194 | -0.504 | 0.235 | 0.278 |
| Dividends per Share |